What is the price target for OM stock?
13 analysts have analysed OM and the average price target is 10.71 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 3.255.
NASDAQ:OM • US6901452069
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OUTSET MEDICAL INC (OM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-12 | BTIG | Maintains | Buy -> Buy |
| 2026-01-07 | Stifel | Maintains | Buy -> Buy |
| 2025-12-16 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-11 | BTIG | Maintains | Buy -> Buy |
| 2025-11-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-11 | Stifel | Maintains | Buy -> Buy |
| 2025-08-19 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-01-07 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-08 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-08 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-06-21 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-04-08 | BTIG | Initiate | Buy |
| 2024-01-12 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-12-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-13 | Stifel | Maintains | Buy -> Buy |
| 2023-10-13 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-08-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-17 | CL King | Initiate | Neutral |
| 2023-08-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 130.376M 12.98% | 113.689M -12.80% | 119.476M 5.09% | 130.42M 9.16% | 145.02M 11.19% | 165.21M 13.92% | 184.47M 11.66% | 205.69M 11.50% | |
| EBITDA YoY % growth | -163.96M -5.22% | -102.671M 37.38% | -62.373M 39.25% | -44.427M 28.77% | -38.179M 14.06% | -21.63M 43.35% | -9.064M 58.10% | 5.356M 159.09% | |
| EBIT YoY % growth | -169.77M -5.45% | -108.399M 36.15% | -66.714M 38.46% | -45.758M 31.41% | -36.102M 21.10% | -23.793M 34.09% | -11.021M 53.68% | 3.502M 131.78% | |
| Operating Margin | -130.22% | -95.35% | -55.84% | -35.08% | -24.89% | -14.40% | -5.97% | 1.70% | |
| EPS YoY % growth | -46.50 9.09% | -27.00 41.94% | -5.61 79.22% | -2.92 47.95% | -2.42 17.28% | -1.84 23.67% | -1.16 36.87% | -0.27 76.99% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.80 75.36% | -0.75 10.18% | -0.70 -1.51% | -0.67 20.71% |
| Revenue Q2Q % growth | 29.69M -0.21% | 32.188M 2.45% | 33.235M 12.93% | 34.711M 20.22% |
| EBITDA Q2Q % growth | -12.085M 19.99% | -11.433M 20.69% | -10.369M 16.06% | -9.751M 26.62% |
| EBIT Q2Q % growth | -12.643M 22.90% | -12.128M 28.09% | -10.987M 30.52% | -10.266M 41.77% |
All data in USD
13 analysts have analysed OM and the average price target is 10.71 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 3.255.
OUTSET MEDICAL INC (OM) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of OUTSET MEDICAL INC (OM) is -0.8 USD and the consensus revenue estimate is 29.69M USD.
The number of analysts covering OUTSET MEDICAL INC (OM) is 13.